Clinical Trial Update: Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update for pemetrexed disodium in malignant pleural mesothelioma patients without progression after first-line chemotherapy; results completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2019-03-05